COMBINATION OF HMG-CoA REDUCTASE INHIBITORS WITH PHOSPHODIESTERASE 4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES
- 专利权人:
- AstraZeneca AB
- 发明人:
- Marx, Degenhard,Braun, Clemens,Wollin, Stefan-Lutz,Wohlsen, Andrea
- 申请号：
- NO20090370
- 公开号：
- NO342590B1
- 申请日:
- 2009.01.27
- 申请国别(地区):
- NO
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to PDE4 inhibitor and HMG-CoA reductase inhibitor is used in combination for the preventative or curative therapy of inflammatory lung disease.Oppfinnelsen vedrører den kombinerte anvendelsen av en PDE4-inhibitor med en HMG-CoA-reduktaseinhibitor for den forebyggende og helbredende behandlingen av en inflammatorisk lungesykdom.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITIONS COMBINATION AND KITS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- PHARMACEUTICAL COMPOSITIONS COMBINATIONS AND KITS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- PHARMACEUTICAL COMPOSITIONS COMBINATIONS AND KITS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- TREATMENT OF ARTERIAL WALL BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
